TEMPUS AI INC (TEM) Stock Price, Quote, News and Overview
NASDAQ:TEM - Nasdaq - US88023B1035 - Common Stock - Currency: USD
TEM Quote, Performance and Key Statistics
68.09
-8.63 (-11.25%)
The current stock price of TEM is 68.09 USD. In the past month the price increased by 24.16%.
TEM Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 24.36 | 203.70B | ||
| DHR | DANAHER CORP | 28.07 | 151.18B | ||
| A | AGILENT TECHNOLOGIES INC | 25.59 | 38.62B | ||
| IQV | IQVIA HOLDINGS INC | 17.15 | 33.64B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 31.26 | 26.91B | ||
| WAT | WATERS CORP | 31.58 | 22.26B | ||
| ICLR | ICON PLC | 14.39 | 16.63B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 31.25 | 15.27B | ||
| ILMN | ILLUMINA INC | 38.45 | 14.94B | ||
| RVTY | REVVITY INC | 23.23 | 13.85B | ||
| AVTR | AVANTOR INC | 17.3 | 11.78B | ||
| MEDP | MEDPACE HOLDINGS INC | 26.94 | 10.37B |
Related stock screener links
About TEM
Company Profile
Tempus AI Inc is a US-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Chicago, Illinois. The company went IPO on 2024-06-14. Tempus AI, Inc. is a technology company. The firm provides next generation diagnostics across multiple disease areas, with technology capabilities, harnessing the data and analytics to help personalize medicine. The Company’s product lines include genomics, data, and artificial intelligence applications (AI). Its genomics product line leverages its laboratories to provide next generation sequencing, diagnostics, polymerase chain reaction (PCR), profiling, molecular genotyping, and other anatomic and molecular pathology testing. The firm's AI applications are focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools. Its primary product of AI applications is Next, an AI platform that leverages machine learning to apply an intelligent layer onto routinely generated data to proactively identify and minimize care gaps for oncology and cardiology patients.
Company Info
TEMPUS AI INC
600 West Chicago Avenue, Suite 510
Chicago ILLINOIS US
Employees: 0
Company Website: https://www.tempus.com/
Phone: 18009765448
TEMPUS AI INC / TEM FAQ
What is the stock price of TEMPUS AI INC today?
The current stock price of TEM is 68.09 USD. The price decreased by -11.25% in the last trading session.
What is the ticker symbol for TEMPUS AI INC stock?
The exchange symbol of TEMPUS AI INC is TEM and it is listed on the Nasdaq exchange.
On which exchange is TEM stock listed?
TEM stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for TEMPUS AI INC stock?
14 analysts have analysed TEM and the average price target is 58.03 USD. This implies a price decrease of -14.78% is expected in the next year compared to the current price of 68.09. Check the TEMPUS AI INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is TEMPUS AI INC worth?
TEMPUS AI INC (TEM) has a market capitalization of 10.72B USD. This makes TEM a Large Cap stock.
How many employees does TEMPUS AI INC have?
TEMPUS AI INC (TEM) currently has 0 employees.
What are the support and resistance levels for TEMPUS AI INC (TEM) stock?
TEMPUS AI INC (TEM) has a support level at 68.08. Check the full technical report for a detailed analysis of TEM support and resistance levels.
Is TEMPUS AI INC (TEM) expected to grow?
The Revenue of TEMPUS AI INC (TEM) is expected to grow by 32.36% in the next year. Check the estimates tab for more information on the TEM EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy TEMPUS AI INC (TEM) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of TEM, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of TEM, evaluating the profitability, health, valuation and growth aspects
- TEMPUS AI INC (TEM) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- TEMPUS AI INC (TEM) Sales and EPS estimates to see what analysts future expectations are.
- TEMPUS AI INC (TEM) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- TEMPUS AI INC (TEM) Insider and Institutional Ownership to learn about the owners and their transactions.
- TEMPUS AI INC (TEM) Stock Chart to make your own analysis
- TEMPUS AI INC (TEM) Latest news and press-releases to stay up to date.
Does TEMPUS AI INC (TEM) stock pay dividends?
TEM does not pay a dividend.
When does TEMPUS AI INC (TEM) report earnings?
TEMPUS AI INC (TEM) will report earnings on 2025-02-24.
What is the Price/Earnings (PE) ratio of TEMPUS AI INC (TEM)?
TEMPUS AI INC (TEM) does not have a PE ratio as the earnings reported over the last twelve months were negative (-8.29).
What is the Short Interest ratio of TEMPUS AI INC (TEM) stock?
The outstanding short interest for TEMPUS AI INC (TEM) is 18.96% of its float. Check the ownership tab for more information on the TEM short interest.
TEM Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to TEM.
TEM Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to TEM. While TEM seems to be doing ok healthwise, there are quite some concerns on its profitability.
TEM Financial Highlights
Over the last trailing twelve months TEM reported a non-GAAP Earnings per Share(EPS) of -8.29. The EPS increased by 20.69% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -82.4% | ||
| ROE | -1490.3% | ||
| Debt/Equity | 8.17 |
TEM Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to TEM. The Buy consensus is the average rating of analysts ratings from 14 analysts.
For the next year, analysts expect an EPS growth of -107.02% and a revenue growth 32.36% for TEM